Nisa Investment Advisors LLC Sells 6,295 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Nisa Investment Advisors LLC reduced its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 9.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 60,738 shares of the company's stock after selling 6,295 shares during the quarter. Nisa Investment Advisors LLC's holdings in HCA Healthcare were worth $20,988,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the business. Rehmann Capital Advisory Group lifted its holdings in HCA Healthcare by 7.1% during the 1st quarter. Rehmann Capital Advisory Group now owns 971 shares of the company's stock worth $336,000 after purchasing an additional 64 shares in the last quarter. AlphaStar Capital Management LLC boosted its holdings in HCA Healthcare by 9.7% in the 1st quarter. AlphaStar Capital Management LLC now owns 8,490 shares of the company's stock valued at $2,934,000 after purchasing an additional 748 shares during the period. Valeo Financial Advisors LLC raised its position in shares of HCA Healthcare by 8.1% in the first quarter. Valeo Financial Advisors LLC now owns 1,013 shares of the company's stock worth $350,000 after buying an additional 76 shares in the last quarter. Brown Advisory Inc. grew its position in HCA Healthcare by 53.9% during the first quarter. Brown Advisory Inc. now owns 4,630 shares of the company's stock worth $1,600,000 after buying an additional 1,622 shares in the last quarter. Finally, Planning Directions Inc. purchased a new stake in shares of HCA Healthcare in the 1st quarter valued at about $201,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Trading Down 0.7%

Shares of HCA stock traded down $2.56 during trading hours on Friday, reaching $375.76. The company's stock had a trading volume of 877,097 shares, compared to its average volume of 1,460,319. The firm's fifty day simple moving average is $375.13 and its 200 day simple moving average is $341.98. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The stock has a market capitalization of $90.40 billion, a P/E ratio of 16.71, a P/E/G ratio of 1.30 and a beta of 1.47. The company has a current ratio of 1.19, a quick ratio of 1.06 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping the consensus estimate of $5.75 by $0.70. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The firm had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. During the same period last year, the company posted $5.36 EPS. The company's quarterly revenue was up 5.7% compared to the same quarter last year. Equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Monday, June 16th were issued a $0.72 dividend. The ex-dividend date of this dividend was Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.77%. HCA Healthcare's dividend payout ratio (DPR) is 12.81%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the transaction, the chief operating officer owned 12,646 shares of the company's stock, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.30% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have issued reports on HCA. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Barclays set a $416.00 price target on HCA Healthcare and gave the company an "overweight" rating in a research report on Monday, June 2nd. Guggenheim assumed coverage on HCA Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating on the stock. Wells Fargo & Company raised HCA Healthcare from an "underweight" rating to an "equal weight" rating and upped their target price for the stock from $320.00 to $385.00 in a research note on Thursday, May 29th. Finally, Robert W. Baird reaffirmed a "neutral" rating and set a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Seven investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare has an average rating of "Moderate Buy" and a consensus target price of $395.71.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.